These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21078612)

  • 21. Warfarin resistance and enteral tube feeding: a vitamin K-independent interaction.
    Dickerson RN
    Nutrition; 2008 Oct; 24(10):1048-52. PubMed ID: 18602249
    [No Abstract]   [Full Text] [Related]  

  • 22. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major bleeding risk associated with warfarin and co-medications in the elderly population.
    Vitry AI; Roughead EE; Ramsay EN; Preiss AK; Ryan P; Gilbert AL; Caughey GE; Shakib S; Esterman A; Zhang Y; McDermott RA
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1057-63. PubMed ID: 22039594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.
    Martins MA; Carlos PP; Ribeiro DD; Nobre VA; César CC; Rocha MO; Ribeiro AL
    Eur J Clin Pharmacol; 2011 Dec; 67(12):1301-8. PubMed ID: 21701882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbidity and mortality associated with the interaction of miconazole oral gel and warfarin.
    Pemberton MN
    Br Dent J; 2018 Jul; 225(2):129-132. PubMed ID: 30050203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacometabonomics Technique to Identify Warfarin Response Using Nuclear Magnetic Resonance Spectroscopy.
    Bawadikji AA; Teh CH; Kader MABSA; Sulaiman SAS; Ibrahim B
    Curr Pharm Biotechnol; 2017; 18(9):740-747. PubMed ID: 29110602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial prescribing and warfarin: a review.
    Rice PJ; Perry RJ; Afzal Z; Stockley IH
    Br Dent J; 2003 Apr; 194(8):411-5. PubMed ID: 12778089
    [No Abstract]   [Full Text] [Related]  

  • 29. Nystatin and miconazole: pharmacological and clinical evidence regarding interactions with warfarin.
    Pemberton MN
    Oral Dis; 2016 Nov; 22(8):761-765. PubMed ID: 27416928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation with warfarin in infants and children.
    Buck ML
    Ann Pharmacother; 1996 Nov; 30(11):1316-22. PubMed ID: 8913415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation with warfarin. A review of monitoring issues.
    Vogel E
    Adv Nurse Pract; 2001 Jan; 9(1):75-8, 81, 94. PubMed ID: 12416044
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
    Shah SR; Martin R; Dowell JE; Ussery SM
    Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistance to warfarin in a patient with hereditary thrombophilia].
    Haastrup P; Rudbæk T; Bove J
    Ugeskr Laeger; 2013 Oct; 175(43):2572-3. PubMed ID: 24629157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis.
    Sanderson S; Emery J; Higgins J
    Genet Med; 2005 Feb; 7(2):97-104. PubMed ID: 15714076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin and its interactions with foods, herbs and other dietary supplements.
    Nutescu EA; Shapiro NL; Ibrahim S; West P
    Expert Opin Drug Saf; 2006 May; 5(3):433-51. PubMed ID: 16610971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions.
    Zhang K; Young C; Berger J
    J Manag Care Pharm; 2006 Oct; 12(8):640-8. PubMed ID: 17269842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
    Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?
    Duke Med Health News; 2012 Jan; 18(1):8. PubMed ID: 22324070
    [No Abstract]   [Full Text] [Related]  

  • 39. Current recommendations for warfarin therapy. Use and monitoring.
    Triplett DA
    Med Clin North Am; 1998 May; 82(3):601-11. PubMed ID: 9646782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
    Chai-Adisaksopha C; Hillis C; Isayama T; Lim W; Iorio A; Crowther M
    J Thromb Haemost; 2015 Nov; 13(11):2012-20. PubMed ID: 26356595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.